People
General Partner at Norwest
- Current affiliation
- Norwest Venture Partners · general_partner
- Investment range
- $100K – $5M
- Sweet spot
- $1M
- Investments on record
- 20
Investments
| $80M2026-04-07 | Endovascular Engineering | Zack Scott |
| $100M2025-09-03 | Galvanize Therapeutics | Zack Scott |
| $120M2025-08-11 |  SetPoint Medical | Zack Scott |
| $130M2025-08-07 |  Apreo Health | Zack Scott |
| $12M2025-03-27 | SetPoint Medical | Zack Scott |
| $100M2024-10-10 |  CytoVale | Zack Scott |
| $66M2024-10-09 |  ShiraTronics | Norwest Venture Partners, Zack Scott |
| $4M2024-06-27 |  VenoStent | Zack Scott |
| $96M2024-04-11 | Nectero Medical | Zack Scott |
| $84M2023-11-15 | CytoVale | Zack Scott |
| $26M2023-06-06 | Vertos Medical | Zack Scott |
| $80M2023-01-19 | SetPoint Medical | Norwest Venture Partners, Zack Scott |
| $30M2020-05-28 | Syapse | Zack Scott |
| $25M2018-09-20 | Providence Medical Technology | Zack Scott |
| $4M2015-06-23 | Cianna Medical | Zack Scott |
| $—2014-12-05 | VisionCare Ophthalmic Technologies | Zack Scott |
| $21M2011-12-16 | Radius Health | Zack Scott |
| $66M2011-07-26 | Radius Health | Zack Scott |
| $12M2011-04-28 | Cianna Medical | Zack Scott |
| $31M2011-01-10 | VisionCare Ophthalmic Technologies | Zack Scott |
Roles
Norwest Venture Partners
Currentgeneral_partner
CytoVale
CurrentBoard Member
ShiraTronics
CurrentBoard Member